Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,725 | 46,823 | 28,130 | 29,757 | 35,531 |
| TOTAL | $53,263 | $49,939 | $32,025 | $33,428 | $38,373 |
| Non-Current Assets | |||||
| PPE Net | 8 | 11 | 18 | 25 | 32 |
| TOTAL | $8 | $11 | $18 | $25 | $32 |
| Total Assets | $53,271 | $49,950 | $32,043 | $33,453 | $38,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 948 | 1,061 | 1,112 | 931 | 1,690 |
| Accrued Expenses | 1,356 | 3,613 | 1,639 | 2,839 | 1,810 |
| TOTAL | $3,547 | $5,872 | $3,667 | $4,501 | $4,341 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,243 | 1,198 | 917 | 731 | 841 |
| TOTAL | $754 | $1,050 | $1,091 | $641 | $694 |
| Total Liabilities | $4,301 | $6,922 | $4,758 | $5,142 | $5,035 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,457 | 23,457 | 20,924 | 16,725 | 16,725 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -69,170 | -61,963 | -56,255 | -54,139 | -48,044 |
| TOTAL | $48,970 | $43,028 | $27,285 | $28,310 | $33,370 |
| Total Liabilities And Equity | $53,271 | $49,950 | $32,043 | $33,453 | $38,405 |